What’s at stake as Beijing beats global peers with first approval of novel therapy

China's drug regulator approved a novel medicine ahead of the United States, Japan, and Europe, marking a historic breakthrough in biopharmaceuticals. The drug was filed for approval in multiple countries, with China being the first to approve it.